We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Wants More Vigilance for Implantable Lenses
UK Wants More Vigilance for Implantable Lenses
January 30, 2009
Intraocular lens (IOL) manufacturers should clearly note any foreseeable adverse events in the product labeling and subject such events to trend analysis as part of their postmarket surveillance system, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) says in a new guidance on vigilance for CE-marked IOLs.